Europe Nebulizer Market

Europe Nebulizer Market Size (2023 to 2028)

The size of the European nebulizer market is estimated to be growing at a CAGR of 9.08% from 2023 to 2028.

Growing innovations of new product types in "nebulizers" is one of the primary factors driving the European nebulizers market. In addition, Y-O-Y growth in the prevalence of asthma and COPD and technological advancements are also contributing significantly to the growth of the European market. According to the WHO, in 2019, around 5.9 million people suffered from chronic obstructive disorder (COPD) in Europe, and the incidence rate increased by 6.9% compared to the previous year, 2019. The increasing prevalence of respiratory diseases such as cystic fibrosis, emphysema, COPD, and asthma is estimated to fuel the growth rate of the European nebulizer market during the forecast period.

Technological advancements are also a key factor promoting the growth rate of the European nebulizer market. The manufacturers of nebulizers are increasingly investing in smart nebulizers that both adults and children can use. Smart or intelligent nebulizers are compatible with applications and connected to smartphones. During the forecast period, the increase in the geriatric population and the increased demand for home care devices such as wearable devices are expected to drive the market growth and the popularity of home nebulization apparatus.

Residential areas, manufacturing units, thermal power plants, and the transportation sector are the main sources of air pollution, causing an increase in deaths attributed to asthma, obstructive pulmonary disease chronic (COPD), and other breathing problems. This boosts the market for nebulizers, as these devices are used to aerosolize the drug and deliver it directly to the lungs.

The reduction in the number of drugs during nebulization is expected to restrict the market growth slightly. In addition, the spray technique may hamper the market during the forecast period as it will cause drug wastage during the expiration, thus compromising the growth of the nebulizer market during the period. The availability of alternatives in the market, contamination of the nebulizers, and the associated maintenance issues are also hampering the market's growth.

Impact of COVID-19 on the European nebulizers market:

The increase in COVID-19 cases around the world has increased the demand for nebulizers. The severe shortage of these devices in medical settings is helping the growth of the nebulizer market as COVID-19 is a lung infection sweeping the world. In addition, the use of the device to treat patients affected by the coronavirus is growing during the COVID-19 pandemic. According to the WHO, more than 182 countries are affected by COVID-19. India, Italy, Spain, the United Kingdom, France, Spain, Iran, Germany, the Netherlands, and Belgium accounted for more than 78% of the cases. With 25% to 45% and 7% to 16% of COVID-19 patients requiring hospitalization and intensive / emergency care, the demand for medical ventilators and nebulizers to deliver drugs directly to the lungs is expected to increase dramatically between 2020 and 2022.

The Europe Nebulizer Market Research Report has been segmented and sub-segmented into the following categories.

By Product:

• Jet Nebulizer
• Mesh Nebulizer
• Ultrasonic Nebulizer

By Modality:

• Portable
• Table-top

By End-User:

• Hospitals
• Clinics
• Home care settings

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, The UK nebulizer market was the largest regional market in the European region and accounted for 48.8% of the European market share in 2020. Among European countries, the UK recorded 83,000 deaths in 2019, according to statistics due to COVID-19. As a result, respiratory disease incidence and mortality rates are higher; the gap widens and leads to poorer health outcomes. According to the WHO, COPD is expected to become the third leading cause of death worldwide by 2028. The most disadvantaged communities have a higher incidence of smoking, exposure to higher levels of air pollution, poor housing conditions, and exposure to occupational hazards, which increase respiratory disorders among the population.

The COVID-19 pandemic has led to an increase in the nebulizer market in Italy and Spain, especially for the elderly population, so considerable growth is expected in these countries. The situation of the COVID-19 pandemic has significantly affected increased in Germany, Netherlands, Belgium, and Switzerland. The number of people affected by COVID-19 is higher; more than a thousand people are affected by the coronavirus. Large numbers of people enter emergency rooms and use ventilators.

KEY MARKET PLAYERS:

Briggs Healthcare, Besco Medical, Ca-Mi, De Vilbiss Healthcare, Feellife Health, Flyp, Invacare, Omron, Philips Respironics, and Pari Medical are notable players in the European nebulizer market.